Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Could p53 be a target for therapeutic suppression?

E A Komarova1, A V Gudkov

  • 1Department of Molecular Genetics, University of Illinois at Chicago 60607, USA.

Seminars in Cancer Biology
|April 2, 1999
PubMed
Summary

The tumor suppressor p53 causes normal tissue damage during cancer therapy. Suppressing p53 may protect tissues from genotoxic stress and aid recovery, but requires careful consideration of its developmental roles.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IVF protocol efficacy in women with expected suboptimal response depending on ovary stimulation mode.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology·2021
Same author

[Purulent iliopsoitis: etiology, pathogenesis, diagnosis and surgical treatment].

Khirurgiia·2021
Same author

[Treatment of hematogenous osteomyelitis of the femur complicated by pathological fracture].

Khirurgiia·2018
Same author

Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy.

Oncogene·2017
Same author

[Peculiarities of the course, diagnosis and surgical treatment of non-lactating mastitis].

Khirurgiia·2017
Same author

Functional genetics-directed identification of novel pharmacological inhibitors of FAS- and TNF-dependent apoptosis that protect mice from acute liver failure.

Cell death & disease·2016

Area of Science:

  • Molecular Biology
  • Oncology
  • Radiology

Background:

  • The tumor suppressor protein p53 traditionally protects against cancer by inducing growth arrest and apoptosis.
  • However, p53's functions can cause normal tissue damage during genotoxic cancer therapies.
  • This suggests p53 inhibition as a strategy to mitigate treatment side effects.

Purpose of the Study:

  • To analyze the role of p53 in acute and long-term consequences of genotoxic stress in vivo.
  • To evaluate the potential of therapeutic p53 suppression for protecting normal tissues during cancer treatment.

Main Methods:

  • Comparison of p53 wild type and p53-deficient mice exposed to genotoxic stress (gamma irradiation).
  • Analysis of tissue-specific apoptosis patterns and p53 mRNA expression.
  • Assessment of hematopoietic system and epithelial recovery post-irradiation.

Main Results:

  • p53 mediates significant apoptosis in radiosensitive tissues shortly after gamma irradiation.
  • Tissue sensitivity correlates with p53 mRNA expression levels.
  • p53 suppression is crucial for hematopoietic stem and differentiating cell survival and recovery.
  • p53-independent apoptosis occurs in radiosensitive epithelial stem cells, unaffected by p53 status.

Conclusions:

  • p53 plays a critical role in mediating normal tissue damage from genotoxic stress, particularly in the hematopoietic system.
  • Therapeutic suppression of p53 could protect normal tissues and enhance recovery after anti-cancer therapy.
  • Potential complications related to p53's role in normal development must be considered.

Related Experiment Videos